Wednesday, October 8, 2025

Latest

Champignon Brands Adds Key Pharmacognosist to its Special Advisory Committee

This morning Champignon Brands Inc (CSE: SHRM)  announced the appointment of Mr. Jay Kheita, ACPR, to its Special Advisory Committee, where he will help lead the integration of Champignon’s novel and natural treatment protocols into their existing consumer packaged goods portfolio. Khetia holds pharmacy licences in Canada, Australia and England. A graduate of the University of Brighton, where he achieved an honours degree in pharmacy studying the medicinal use of plants.

Khetia, co-founder of AltMed Capital, a leading Canadian psychedelic medicine clinic operator, IP aggregator and solutions provider, is currently a clinical advisor at the Leslie Dan faculty of pharmacy at the University of Toronto.

We are pleased to welcome Jay to Champignon’s Special Advisory Committee, where he will function as a cornerstone advisor throughout our pursuit to develop and deploy precision medicine focused formulations and delivery systems.

Gareth Birdsall, CEO of Champignon

Last week the company announced the acquisition of Tassili Life Sciences Corp; who is currently working in partnership with the University of Miami to develop effective psilocybin-based treatments for post traumatic stress disorder as well as mild traumatic brain injuries.

At the time of publishing, Champignon’s share price has risen 5.0% to 52c.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Supreme Cannabis Posts Declining Fourth Quarter Revenues Of $9.5 Million

Supreme Cannabis (TSX: FIRE) reported their fourth quarter 2020 financial results this evening, posting declining...

Thursday, September 24, 2020, 06:30:24 PM

Alamos Gold Meets 2021 Production Guidance With 457,200 Ounces

Alamos Gold Inc. (TSX: AGI) shared on Monday its production results for Q4 and full-year...

Tuesday, January 18, 2022, 11:42:00 AM

Iron Ore And Metallurgical Coal Are Counterintuitively Moving In Wildly Diverging Directions

In one of the most surprising steel-related commodities markets ever, the price of one key...

Monday, September 20, 2021, 04:46:00 PM

IAMGOLD Records US$297.4 Million In Revenue For Q1 2021

IAMGOLD Corporation (TSX: IMG) reported today its financial results for Q1 2021, highlighting revenue of...

Tuesday, May 4, 2021, 10:19:00 AM

Chinese Biotech Firm LianBio Prices US$325 Million Nasdaq IPO

Biotech company LianBio (Nasdaq: LIAN) started trading on the Nasdaq Global Market today. The Shanghai-based...

Monday, November 1, 2021, 02:07:00 PM